Jun Luo

2.0k total citations
67 papers, 1.4k citations indexed

About

Jun Luo is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Jun Luo has authored 67 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Cancer Research and 19 papers in Hepatology. Recurrent topics in Jun Luo's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (7 papers). Jun Luo is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (7 papers). Jun Luo collaborates with scholars based in China, United States and Australia. Jun Luo's co-authors include Ming Shi, Min-Shan Chen, Rong Guo, Eric C. H. Lai, Yaojun Zhang, Wan Yee Lau, Jiafu Feng, Ping Zeng, Yuwei Yang and Tinghe Yu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jun Luo

63 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Luo China 19 584 389 327 283 241 67 1.4k
Yihong Ling China 21 355 0.6× 346 0.9× 240 0.7× 354 1.3× 191 0.8× 58 1.2k
Zhangjun Cheng China 20 452 0.8× 560 1.4× 474 1.4× 296 1.0× 92 0.4× 65 1.4k
Zachary J. Brown United States 17 520 0.9× 443 1.1× 378 1.2× 698 2.5× 136 0.6× 69 1.9k
Jiasheng Zheng China 20 312 0.5× 321 0.8× 172 0.5× 269 1.0× 228 0.9× 54 1.0k
Ying‐Chun Shen Taiwan 26 677 1.2× 638 1.6× 526 1.6× 686 2.4× 322 1.3× 90 2.1k
Jeong Eun Yoo South Korea 24 682 1.2× 682 1.8× 418 1.3× 480 1.7× 116 0.5× 48 1.8k
Takashi Niizeki Japan 22 747 1.3× 184 0.5× 244 0.7× 326 1.2× 228 0.9× 70 1.2k
Genís Campreciós Spain 12 532 0.9× 423 1.1× 298 0.9× 437 1.5× 131 0.5× 25 1.4k
Masahiro Takita Japan 26 1.4k 2.3× 429 1.1× 411 1.3× 397 1.4× 370 1.5× 77 2.1k
Ao Huang China 21 572 1.0× 725 1.9× 787 2.4× 574 2.0× 228 0.9× 51 1.9k

Countries citing papers authored by Jun Luo

Since Specialization
Citations

This map shows the geographic impact of Jun Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Luo more than expected).

Fields of papers citing papers by Jun Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Luo. The network helps show where Jun Luo may publish in the future.

Co-authorship network of co-authors of Jun Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Luo. A scholar is included among the top collaborators of Jun Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Luo. Jun Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Chunxiao, Tongtong Huang, Chunlan Jiang, et al.. (2025). Right Atrial Stiffness Assessed by Speckle‐Tracking Echocardiography: An Incremental Prognostic Indicator for Light‐Chain Cardiac Amyloidosis. Echocardiography. 42(11). e70343–e70343.
4.
Dai, Yi, et al.. (2024). The clinical efficacy of a daratumumab-based regimen in relapsed/refractory acute leukemia: a single-center experience. Annals of Hematology. 103(10). 4057–4063. 2 indexed citations
5.
Yang, Ruifu, Xiaotong Huang, Keyu Zeng, et al.. (2024). Feasibility of large language models for CEUS LI-RADS categorization of small liver nodules in patients at risk for hepatocellular carcinoma. Frontiers in Oncology. 14. 1513608–1513608. 1 indexed citations
6.
Shao, Guoliang, Hui Zeng, Zhewei Zhang, Jun Luo, & Dinghu Zhang. (2024). Fruquintinib combined with sintilimab plus transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma: A single-arm phase II study.. Journal of Clinical Oncology. 42(3_suppl). 499–499. 1 indexed citations
7.
Liu, Aijun, Lihong Liu, Wei Wang, et al.. (2023). Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: a retrospective multicenter study from China. BMC Cancer. 23(1). 930–930. 1 indexed citations
8.
Song, Danjun, Xi Wang, Yining Wang, et al.. (2023). Integrated Analysis of N1-Methyladenosine Methylation Regulators-Related lncRNAs in Hepatocellular Carcinoma. Cancers. 15(6). 1800–1800. 7 indexed citations
9.
Luo, Jun, Qing Zhou, Qin Chen, et al.. (2021). The value of contrast‐enhanced ultrasound in determining the location of sentinel lymph nodes in breast cancer. Cancer Imaging. 21(1). 28–28. 9 indexed citations
10.
Wang, Gang, et al.. (2021). Clinicopathological factors associated with synchronous distant metastasis and prognosis of stage T1 colorectal cancer patients. Scientific Reports. 11(1). 8722–8722. 11 indexed citations
12.
Chen, Yijie, Zhaoming Zhong, Qin Chen, et al.. (2019). <p>A multicenter study of a contrast-enhanced ultrasound diagnostic classification of breast lesions</p>. Cancer Management and Research. Volume 11. 2163–2170. 11 indexed citations
13.
Zeng, Hui, Jiaping Zheng, Wen Song, et al.. (2019). <p>MicroRNA-339 inhibits human hepatocellular carcinoma proliferation and invasion via targeting ZNF689</p>. Drug Design Development and Therapy. Volume 13. 435–445. 17 indexed citations
14.
Tian, Ye, et al.. (2018). CircNUP214 sponges miR-145 to promote the expression of ZEB2 in thyroid cancer cells. Biochemical and Biophysical Research Communications. 507(1-4). 168–172. 37 indexed citations
15.
Zhong, Gang, Ruiming Liang, Jun Yao, et al.. (2018). Artemisinin Ameliorates Osteoarthritis by Inhibiting the Wnt/β-Catenin Signaling Pathway. Cellular Physiology and Biochemistry. 51(6). 2575–2590. 34 indexed citations
16.
Li, Jing, et al.. (2017). SOX6 Downregulation Induces γ-Globin in Human β-Thalassemia Major Erythroid Cells. BioMed Research International. 2017. 1–6. 14 indexed citations
17.
Wen, Jing, Hongying Li, Cheng Peng, et al.. (2017). Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome. International Journal of Hematology. 105(6). 777–783. 18 indexed citations
18.
Mao, Weimin, et al.. (2013). [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].. PubMed. 35(8). 590–4. 2 indexed citations
19.
Shi, Ming, Ligong Lu, Rong Guo, et al.. (2012). Roles Played by Chemolipiodolization and Embolization in Chemoembolization for Hepatocellular Carcinoma: Single-Blind, Randomized Trial. JNCI Journal of the National Cancer Institute. 105(1). 59–68. 60 indexed citations
20.
Liang, Yuzhen, Yongrong Lai, Paul Schwarzenberger, et al.. (2010). Targeted Agents for Chronic Myelogenous Leukemia: Will That Be the End of Allogeneic Bone Marrow Transplantation for That Disease?. Biology of Blood and Marrow Transplantation. 16(6). 848–853. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026